Cargando…

Erratum: Protocol for a cross-sectional study: effects of a multiple sclerosis relapse therapy with methylprednisolone on offspring neurocognitive development and behavior (MS-children)

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225901/ https://www.ncbi.nlm.nih.gov/pubmed/37255723 http://dx.doi.org/10.3389/fneur.2023.1213956

Ejemplares similares

Protocol for a Cross-Sectional Study: Effects of a Multiple Sclerosis Relapse Therapy With Methylprednisolone on Offspring Neurocognitive Development and Behavior (MS-Children)
por: Kozik, Valeska, et al.
Publicado: (2022)

Impact of disease-modifying therapies on MRI and neurocognitive outcomes in relapsing–remitting multiple sclerosis: a protocol for a systematic review and network meta-analysis
por: Lees, Samuel, et al.
Publicado: (2021)

Impact of Repetitive Transcranial Magnetic Stimulation on Neurocognition and Oxidative Stress in Relapsing-Remitting Multiple Sclerosis: A Case Report
por: Agüera, Eduardo, et al.
Publicado: (2020)

FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosis
por: Kearns, Patrick K A, et al.
Publicado: (2022)

Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses
por: Caster, Ola, et al.
Publicado: (2015)

Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
por: Pfeuffer, Steffen, et al.
Publicado: (2022)

An Overview of Therapeutic Options in Relapsing-remitting Multiple Sclerosis
por: Saleem, Sidra, et al.
Publicado: (2019)

Evaluation of an interactive web-based programme on relapse management for people with multiple sclerosis (POWER@MS2): study protocol for a process evaluation accompanying a randomised controlled trial
por: Wenzel, Lisa, et al.
Publicado: (2021)

Effect of Seasonal Variation on Relapse Rate in Patients With Relapsing-Remitting Multiple Sclerosis in Saudi Arabia
por: Makkawi, Seraj, et al.
Publicado: (2022)

Health behaviors of people with multiple sclerosis and its associations with MS related outcomes: a German clinical cohort
por: Goldin, Katharina, et al.
Publicado: (2023)

An interactive web-based programme on relapse management for people with multiple sclerosis (POWER@MS2) - development, feasibility, and pilot testing of a complex intervention
por: Wenzel, Lisa, et al.
Publicado: (2022)

Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
por: Roach, Charles A., et al.
Publicado: (2021)

Fine Particulate Matter Related to Multiple Sclerosis Relapse in Young Patients
por: Januel, Edouard, et al.
Publicado: (2021)

Tablet App Based Dexterity Training in Multiple Sclerosis (TAD-MS): Research Protocol of a Randomized Controlled Trial
por: van Beek, Judith J. W., et al.
Publicado: (2019)

A Rare Case of Susac's Syndrome Masquerading as Progressive-Relapsing Multiple Sclerosis
por: Darwish, Nedal, et al.
Publicado: (2022)

Changing physical activity behaviour for people with multiple sclerosis: protocol of a randomised controlled feasibility trial (iStep-MS)
por: Ryan, Jennifer M, et al.
Publicado: (2017)

A Pilot Cross-Sectional Study to Investigate the Biomarker Potential of Phosphorylated Neurofilament-H and Immune Mediators of Disability in Patients With 5 Year Relapsing-Remitting Multiple Sclerosis
por: Herrera, María Inés, et al.
Publicado: (2019)

Balance Changes in Patients With Relapsing-Remitting Multiple Sclerosis: A Pilot Study Comparing the Dynamics of the Relapse and Remitting Phases
por: Findling, Oliver, et al.
Publicado: (2018)

Good multiple sclerosis (MS) care and how to get there in Canada: Perspectives of Canadian healthcare providers working with persons with MS
por: Petrin, Julie, et al.
Publicado: (2023)

OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis
por: Dobson, Ruth, et al.
Publicado: (2021)

Cognitive and Language Deficits in Multiple Sclerosis: Comparison of Relapsing Remitting and Secondary Progressive Subtypes
por: Ntoskou, Katerina, et al.
Publicado: (2018)

Impact of the McDonald Criteria 2017 on Early Diagnosis of Relapsing-Remitting Multiple Sclerosis
por: Schwenkenbecher, Philipp, et al.
Publicado: (2019)

Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
por: Røsjø, Egil, et al.
Publicado: (2020)

Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report
por: Maniscalco, Giorgia T., et al.
Publicado: (2021)

Effect of Obesity on Retinal Integrity in African Americans and Caucasian Americans With Relapsing Multiple Sclerosis
por: Rube, Jacob, et al.
Publicado: (2021)

Association Between Serum Vitamin D Levels and Frequency of Relapses in Patients With Multiple Sclerosis
por: Mansoor, Farah, et al.
Publicado: (2021)

Estimating Risk of Multiple Sclerosis Disease Reactivation in Pregnancy and Postpartum: The VIPRiMS Score
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: a cross-sectional survey
por: Rinker, John R, et al.
Publicado: (2015)

Neurophysiological and clinical biomarkers of secondary progressive multiple sclerosis: A cross-sectional study
por: Tartaglia, Matteo, et al.
Publicado: (2023)

A Cross-Sectional Study of Human Immunodeficiency Virus-Associated Neurocognitive Deficit in Central India
por: Maitra, Dr. Saptarshi, et al.
Publicado: (2021)

Case Report: Baló's Concentric Sclerosis-Like Lesion in a Patient With Relapsing-Remitting Multiple Sclerosis Treated With Dimethyl Fumarate
por: Kania, Karolina, et al.
Publicado: (2022)

Characterization of Upper Limb Impairments at Body Function, Activity, and Participation in Persons With Multiple Sclerosis by Behavioral and EMG Assessment: A Cross-Sectional Study
por: Valè, Nicola, et al.
Publicado: (2020)

Probing Context-Dependent Modulations of Ipsilateral Premotor-Motor Connectivity in Relapsing-Remitting Multiple Sclerosis
por: Ruiu, Elisa, et al.
Publicado: (2020)

Memory Impairment in Relapsing-Remitting Multiple Sclerosis Using a Challenging Semantic Interference Task
por: Matias-Guiu, Jordi A., et al.
Publicado: (2020)

Development and Validation of a Five-Gene Signature to Predict Relapse-Free Survival in Multiple Sclerosis
por: Ye, Fei, et al.
Publicado: (2020)

Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis
por: Alroughani, Raed, et al.
Publicado: (2021)

Vaginal Herpes Zoster While Under Treatment for Relapsing-Remitting Multiple Sclerosis With Diroximel Fumarate
por: Gül, Sedat, et al.
Publicado: (2023)

Multimodal diagnostics in multiple sclerosis: predicting disability and conversion from relapsing-remitting to secondary progressive disease course – protocol for systematic review and meta-analysis
por: Statsenko, Yauhen, et al.
Publicado: (2023)

Cross-Sectional and Longitudinal MRI Brain Scans Reveal Accelerated Brain Aging in Multiple Sclerosis
por: Høgestøl, Einar A., et al.
Publicado: (2019)

Memantine for the Treatment of Behavioral Disturbance in Unspecified Major Neurocognitive Disorder
por: Terry, Peyton H, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0gb75f2citg6ih9aniqsgkf93n